SCANDINAVIAN CHEMOTECH AB B revenue breakdown overview

SCANDINAVIAN CHEMOTECH AB B revenue for the last year amounted to 6.60 M SEK, the most of which — 6.57 M SEK — came from its highest performing source at the moment, Tumor-specific Electroporation Technology, the year earlier bringing 2.82 M SEK. The greatest contribution to the revenue figure was made by Sweden — last year it brought SCANDINAVIAN CHEMOTECH AB B 6.57 M SEK, and the year before that — 2.82 M SEK.